Type 2 Diabetes represents a large burden on public health systems worldwide. The chronic metabolic condition is characterised by hyperglycaemia and insulin resistance and is frequently associated with obesity, hypertension and dyslipidaemia. There is a growing need for effective management techniques of these conditions that patients can utilise complementary to conventional therapy. Apple cider vinegar (ACV) has been the subject of growing interest in this field. The main component of ACV, acetic acid, has demonstrated effectiveness in reducing hyperglycaemia, correcting dyslipidaemia and assisting weight loss. The dominant polyphenol compound in ACV, chlorogenic acid may also be useful in managing the condition.